The COVID-19 pandemic tested the efficiency of healthcare, especially in emerging markets like Indonesia, Malaysia, the Philippines, Thailand, and Vietnam. Most of the industry’s pain points are being solved and automated by AI, and these solutions continue to learn and evolve as they crunch reams of data, but the question remains: Are the regulations ready to catch up with fast-learning AI software in the market?

Kidney diseases are one of the top causes of hospitalization and death globally, and afflict 10,000 Filipinos each year. COVID-19 has further strained already limited resources for kidney patients and hindered clinicians from scaling their services and care. An AI messaging platform is swinging the response from managing kidney disease to stopping it.

Digital therapeutics (DTx) promises to make healthcare more accessible, proactive, and patient-centered, empowering patients, while also giving clinicians the ability to make better diagnoses. To better understand DTx, Michelle Louise Jose, a healthtech pharmacist who prepares natural language processing content, explains how one must first examine the key differences between telemedicine and DTx, as well as the challenges that must be addressed for DTx to fulfill its potential.

The cost of healthcare in Third World countries like the Philippines is expensive but, thanks to artificial intelligence and remote patient monitoring, access to healthcare is improving and becoming more affordable.